200 related articles for article (PubMed ID: 1469784)
1. [Hairy cell leukemia successfully treated with deoxycoformycin].
Matsuda A; Jinnai I; Mizuno H; Sakata T; Kusumoto S; Kayano H; Takeuchi H; Bessho M; Saito M; Katayama I
Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
[TBL] [Abstract][Full Text] [Related]
2. [European-American-type hairy cell leukemia without splenomegaly, treated successfully with deoxycoformycin].
Muta T; Okamura T; Oshima K; Kikuchi M; Niho Y
Rinsho Ketsueki; 2001 May; 42(5):426-31. PubMed ID: 11452464
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of hairy cell leukemia with pentostatin].
Fujita H; Koharazawa H; Nishida H; Terada S; Morishita T; Kuroyama Y; Ohata M; Ishigatsubo Y
Rinsho Ketsueki; 2001 Jul; 42(7):537-42. PubMed ID: 11524843
[TBL] [Abstract][Full Text] [Related]
4. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group.
Shimoyama M; Tobinai K; Yamaguchi K; Hirashima K; Itoh S; Konishi H; Mikuni C; Togawa A; Hotta T; Toyoda N
Jpn J Clin Oncol; 1992 Dec; 22(6):406-10. PubMed ID: 1291757
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.
Lauria F; Lenoci M; Annino L; Raspadori D; Marotta G; Bocchia M; Forconi F; Gentili S; La Manda M; Marconcini S; Tozzi M; Baldini L; Zinzani PL; Foà R
Haematologica; 2001 Oct; 86(10):1046-50. PubMed ID: 11602410
[TBL] [Abstract][Full Text] [Related]
7. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
Shibata T; Hotta T
Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
[TBL] [Abstract][Full Text] [Related]
8. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K
Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
[TBL] [Abstract][Full Text] [Related]
9. Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide.
Strupp C; Fenk R; Kündgen A; Gattermann N; Haas R; Germing U
Leuk Res; 2005 Aug; 29(8):967-9. PubMed ID: 15978949
[TBL] [Abstract][Full Text] [Related]
10. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
11. [Hairy cell leukemia expressing SIgM+, SIgG-, CD11b+ and CD21+ and accompanying lymphadenopathy without splenomegaly].
Tokioka T; Shimamoto Y; Ohkubo Y; Fukuoka M; Ohgushi K; Nagumo F; Wakayama K; Yamaguchi M
Rinsho Ketsueki; 1991 Feb; 32(2):156-61. PubMed ID: 1827508
[TBL] [Abstract][Full Text] [Related]
12. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
[TBL] [Abstract][Full Text] [Related]
13. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
[TBL] [Abstract][Full Text] [Related]
14. [Successful treatment of hairy cell leukemia prolymphocytic variant with 2'-deoxycoformycin].
Nagai T; Izumi T; Noborio K; Takatoku M; Ohtsuki T; Machii T; Komatsu N; Ozawa K
Rinsho Ketsueki; 2002 Jul; 43(7):583-5. PubMed ID: 12229130
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC
Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066
[TBL] [Abstract][Full Text] [Related]
17. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
[TBL] [Abstract][Full Text] [Related]
18. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
[TBL] [Abstract][Full Text] [Related]
20. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
Kraut EH
Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
